IDEXX Laboratories Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 IDEXX Laboratories Inc 公司

IDEXX Laboratories, Inc. 開發、生產和分銷產品，並主要爲伴侶動物獸醫、牲畜和家禽、乳製品和水檢測行業提供服務。該公司還提供人類醫療即時診斷和實驗室診斷。其部門包括伴侶動物組 (CAG)、水質產品 (水) 以及牲畜、家禽和乳製品 (LPD)。CAG 部門爲伴侶動物獸醫行業提供基於診斷和信息管理的產品和服務，包括臨牀診斷解決方案、外部參考實驗室服務以及獸醫軟件和服務。其水部門提供測試解決方案，用於準確檢測和量化水中的各種微生物參數。其 LPD 部門提供診斷測試、服務和相關儀器，用於管理牲畜和家禽的健康狀況，以提高牛奶的質量和安全性。

IDEXX Laboratories Inc簡介



公司代碼IDXX

公司名稱IDEXX Laboratories Inc

上市日期Jun 21, 1991

CEOMr. Andrew Emerson

員工數量11000

證券類型Ordinary Share

年結日Jun 21

公司地址One Idexx Drive

城市WESTBROOK

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編04092-2041

電話12075560300

網址https://www.idexx.com/

公司代碼IDXX

上市日期Jun 21, 1991

CEOMr. Andrew Emerson

IDEXX Laboratories Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

其他

-697.43M

-62.86%

地區USD

名稱

營收

佔比

United States

717.87M

64.70%

Europe & Middle East & Africa (EMEA) (Region)

233.27M

21.03%

Asia Pacific

89.30M

8.05%

Canada

46.69M

4.21%

Latin America

22.33M

2.01%

業務

地區

業務USD

名稱

營收

佔比

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

其他

-697.43M

-62.86%

股東統計

更新時間: 8月19日週二

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Investment Management (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

其他

70.25%

持股股東

佔比

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Investment Management (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

其他

70.25%

股東類型

持股股東

佔比

Investment Advisor

54.15%

Investment Advisor/Hedge Fund

32.38%

Research Firm

3.94%

Pension Fund

2.49%

Bank and Trust

2.04%

Hedge Fund

0.90%

Individual Investor

0.69%

Sovereign Wealth Fund

0.60%

Family Office

0.54%

其他

2.27%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

2278

77.56M

96.93%

-3.76M

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

9.84M

12.3%

+19.20K

+0.20%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.30M

6.63%

-132.86K

-2.44%

Jun 30, 2025

State Street Investment Management (US)

3.55M

4.44%

-95.45K

-2.62%

Jun 30, 2025

Fundsmith LLP

2.64M

3.3%

-9.04K

-0.34%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.46M

3.08%

+54.40K

+2.26%

Jun 30, 2025

Baron Capital Management, Inc.

2.03M

2.54%

-27.16K

-1.32%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

1.65M

2.06%

-5.80K

-0.35%

Aug 31, 2025

Polen Capital Management, LLC

1.20M

1.49%

+1.12M

+1519.07%

Jun 30, 2025

Principal Global Investors (Equity)

1.13M

1.41%

+1.75K

+0.16%

Jun 30, 2025

William Blair & Company, L.L.C. (Research)

1.08M

1.35%

-10.27K

-0.94%

Jun 30, 2025

持股ETF



更新時間: 10月6日週一

機構名稱

佔比

ProShares Pet Care ETF

9.54%

iShares U.S. Medical Devices ETF

5.48%

First Trust Water ETF

5.43%

Hennessy Sustainable ETF

3.75%

Nuveen ESG Mid-Cap Growth ETF

3.53%

Adaptive Core ETF

2.75%

Invesco Raymond James SB-1 Equity ETF

2.49%

First Trust S&P 500 Economic Moat Index ETF

2.37%

SPDR S&P Health Care Equipment ETF

2.24%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

2.19%

ProShares Pet Care ETF

佔比9.54%

iShares U.S. Medical Devices ETF

佔比5.48%

First Trust Water ETF

佔比5.43%

Hennessy Sustainable ETF

佔比3.75%

Nuveen ESG Mid-Cap Growth ETF

佔比3.53%

Adaptive Core ETF

佔比2.75%

Invesco Raymond James SB-1 Equity ETF

佔比2.49%

First Trust S&P 500 Economic Moat Index ETF

佔比2.37%

SPDR S&P Health Care Equipment ETF

佔比2.24%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

佔比2.19%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據